open access

Vol 7, No 3 (2003)
Prace oryginalne
Published online: 2003-07-21
Get Citation

Erectile Dysfunction in Men with Essential Arterial Hypertension

Marek Klocek, Marek Rajzer, Kalina Kawecka-Jaszcz
Nadciśnienie tętnicze 2003;7(3):181-189.

open access

Vol 7, No 3 (2003)
Prace oryginalne
Published online: 2003-07-21

Abstract

Background The aim of the study was to analyse the frequency of erectile dysfunction (ED) in men with essential arterial hypertension (EAH) taking into account selected cardiovascular risk factors.
Material and methods The study population consisted of 214 consecutive men with EAH receiving out-patient treatment (mean age 55.3 ± 10.8 years) from whom the following information was obtained: blood pressure values, duration of EAH, current antihypertensive treatment, concomitant diseases, total cholesterol level and beverages. Monotherapy was used in 23.4%, two hypotensive agents were given to 42.1% and three to 34.5%. Lipid disorders were found in 56.1% of men. Of them 65% were receiving hypolipemic agents. There were 83 (38.8%) current smokers in the whole population. The presence and intensity of erectile dysfunction were evaluated from the International Index of Erectile Function (IIEF-5).
Results ED were found in 85 (39.7%) men with EAH. The percentage of ED men was correlated with age (r = 0.61; p < 0.01), duration of EAH (r = 0.43; p < 0.01), smoking (r = 0.33, p < 0.01), dyslipidemia (r = 0.31, p < 0.05), systolic blood pressure (r = 0.30; p < 0.05) and the number of antihypertensive agents (r = 0.27; p < 0.05). Logistic regression analysis for the whole population revealed that a combination of b-blockers and thiazides was associated with elevated ED risk, RR: 1.13 and 1.21; p < 0.05, whereas a combination of long-acting calcium antagonists and a-blockers with lower risk of ED, RR: 0.89 and 0.95; p < 0.05. After adjustment for age and differences in hypotensive treatment the strongest predictor of ED in men with EAH was smoking combined with dyslipidemia (RR: 2.1; 95% CI: 1.45–3.1; p < 0.01).
Conclusions Erectile dysfunction occurs in about 40% of middle-aged men with EAH. Smoking and dyslipidemia are associated with higher ED frequency irrespective of age. ED is more frequent in men receiving a combination of three antihypertensive agents, especially b-blockers and thiazides.

Abstract

Background The aim of the study was to analyse the frequency of erectile dysfunction (ED) in men with essential arterial hypertension (EAH) taking into account selected cardiovascular risk factors.
Material and methods The study population consisted of 214 consecutive men with EAH receiving out-patient treatment (mean age 55.3 ± 10.8 years) from whom the following information was obtained: blood pressure values, duration of EAH, current antihypertensive treatment, concomitant diseases, total cholesterol level and beverages. Monotherapy was used in 23.4%, two hypotensive agents were given to 42.1% and three to 34.5%. Lipid disorders were found in 56.1% of men. Of them 65% were receiving hypolipemic agents. There were 83 (38.8%) current smokers in the whole population. The presence and intensity of erectile dysfunction were evaluated from the International Index of Erectile Function (IIEF-5).
Results ED were found in 85 (39.7%) men with EAH. The percentage of ED men was correlated with age (r = 0.61; p < 0.01), duration of EAH (r = 0.43; p < 0.01), smoking (r = 0.33, p < 0.01), dyslipidemia (r = 0.31, p < 0.05), systolic blood pressure (r = 0.30; p < 0.05) and the number of antihypertensive agents (r = 0.27; p < 0.05). Logistic regression analysis for the whole population revealed that a combination of b-blockers and thiazides was associated with elevated ED risk, RR: 1.13 and 1.21; p < 0.05, whereas a combination of long-acting calcium antagonists and a-blockers with lower risk of ED, RR: 0.89 and 0.95; p < 0.05. After adjustment for age and differences in hypotensive treatment the strongest predictor of ED in men with EAH was smoking combined with dyslipidemia (RR: 2.1; 95% CI: 1.45–3.1; p < 0.01).
Conclusions Erectile dysfunction occurs in about 40% of middle-aged men with EAH. Smoking and dyslipidemia are associated with higher ED frequency irrespective of age. ED is more frequent in men receiving a combination of three antihypertensive agents, especially b-blockers and thiazides.
Get Citation

Keywords

arterial hypertension; erection dysfunction; risk factors

About this article
Title

Erectile Dysfunction in Men with Essential Arterial Hypertension

Journal

Arterial Hypertension

Issue

Vol 7, No 3 (2003)

Pages

181-189

Published online

2003-07-21

Bibliographic record

Nadciśnienie tętnicze 2003;7(3):181-189.

Keywords

arterial hypertension
erection dysfunction
risk factors

Authors

Marek Klocek
Marek Rajzer
Kalina Kawecka-Jaszcz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl